She is a qualified professional with 7 years of experience in the Drug Department, having worked across multiple functions, including the regulation of Narcotics, Psychotropics, and Precursor Chemicals. Her expertise extends to conducting GMP audits both locally and internationally, monitoring drug quality and safety, and investigating malpractice within the industry, all with a focus on ensuring the safe use of medicines across the country.

She has played a pivotal role in strengthening MOHAP’s partnerships with other federal entities, including the Ministry of Interior, the Federal Customs Authority, and the Weapons and Hazardous Substances Office, as well as collaborating with international organizations such as the World Health Organization (WHO) and the International Narcotics Control Board (INCB).